npj Regenerative Medicine (Sep 2022)

Integrin-specific hydrogels for growth factor-free vasculogenesis

  • Helena R. Moreira,
  • Daniel B. Rodrigues,
  • Sara Freitas-Ribeiro,
  • Lucília P. da Silva,
  • Alain da S. Morais,
  • Mariana Jarnalo,
  • Ricardo Horta,
  • Rui L. Reis,
  • Rogério P. Pirraco,
  • Alexandra P. Marques

DOI
https://doi.org/10.1038/s41536-022-00253-4
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Integrin-binding biomaterials have been extensively evaluated for their capacity to enable de novo formation of capillary-like structures/vessels, ultimately supporting neovascularization in vivo. Yet, the role of integrins as vascular initiators in engineered materials is still not well understood. Here, we show that αvβ3 integrin-specific 3D matrices were able to retain PECAM1+ cells from the stromal vascular fraction (SVF) of adipose tissue, triggering vasculogenesis in vitro in the absence of extrinsic growth factors. Our results suggest that αvβ3-RGD-driven signaling in the formation of capillary-like structures prevents the activation of the caspase 8 pathway and activates the FAK/paxillin pathway, both responsible for endothelial cells (ECs) survival and migration. We also show that prevascularized αvβ3 integrin-specific constructs inosculate with the host vascular system fostering in vivo neovascularization. Overall, this work demonstrates the ability of the biomaterial to trigger vasculogenesis in an integrin-specific manner, by activating essential pathways for EC survival and migration within a self-regulatory growth factor microenvironment. This strategy represents an improvement to current vascularization routes for Tissue Engineering constructs, potentially enhancing their clinical applicability.